First Tracks (TRAX) Stock Price, Quote, News & History | Benzinga

SPY777.29−0.16%QQQ743.86−0.99%BTC/USD82,761.54+1.25%DIA518.08+0.38%GLD382.24−0.61%TLT77.97−0.01%

First Tracks Biotherapeutics Inc (TRAX) Stock Price, Quote, News & History

TRAXNASDAQ

Trade with Public

Trade with Public

$34.05

2.206.91%

Last update: Oct 12, 7:56 PM

$34.00

2.156.75%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Stock Report

Key Statistics

Open

$39.45

Close

$34.05

Volume / Avg.

7.31M / 797.53K

Day Range

$34.00 - $34.00

52 Wk Range

14.72 - 49.91

Market Cap

$1.14B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

44

Short Interest

-

Days to Cover

6.19

Recent First Tracks Biotherapeutics Inc News

Dow Gains Over 200 Points; Chipotle Shares Move Lower

U.S. stocks traded mixed: Dow rose 0.47%, S&P 500 edged up, Nasdaq fell; energy led gains, while Chipotle dropped after Starbucks denied takeover rumors.

Avi Kapoor

First Tracks Biotherapeutics, C3.ai, CCC Intelligent Solutions And Other Big Stocks Moving Higher On Monday

U.S. stocks mixed; First Tracks Biotherapeutics surged 18% on positive celiac trial results, while C3.ai, Liquidia and others also gained.

Avi Kapoor

Stock Market Today: S&P 500, Dow Futures Gain, Nasdaq 100 Falls as Iran Flags ‘Inadequate’ US Response to Peace Terms — SMP, QMCO, SVRN in Focus (UPDATED)

U.S. stock futures were mixed on Monday, as the Dow Jones and S&P 500 indices rose, while the Nasdaq 100 index fell.

Rishabh Mishra

Why Is First Tracks Biotherapeutics Stock Soaring Monday?

First Tracks Biotherapeutics (TRAX) stock surged 13% on positive Phase 1b celiac disease trial results for ANB033. Read the update.

Vandana Singh

Why J-Star Holding Shares Are Trading Higher By Around 128%; Here Are 20 Stocks Moving Premarket

J-Star Holding surged 127.9% premarket after funding U.S. drone-frame expansion; Linkers and VCI gained, while Vivakor and China SXT fell.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-125.81M

Investing Cash Flow (TTM)

95.40M

Financing Cash Flow (TTM)

117.52M

Free Cash Flow (TTM)

-126.16M

Capital Expenditure (TTM)

-358.00K

Net Change in Cash (TTM)

87.12M

Analyst Trends and Forecast

1

Jun

5

Jul

5

Aug

4

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$972.91M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

6.73

Earnings Yield % (TTM)

-14.81%

Earnings Yield % (FWD)

-10.58%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$4.72

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$168.02M

Debt to Equity

0.03

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-